Asia Pacific Biobanks Market to 2027- Global Analysis and Forecasts by Product and Service (Equipment, Consumables, Service, and Software), Sample (Blood Products, Human Tissues, Cell Lines, and Others), and Application (Regenerative Medicine, Life Science Research, and Clinical Research)
Publication Month: Mar 2022 | Report Code: TIPRE00028369 | No. of Pages: 172 | Category: Biotechnology | Status: Published
The biobanks market in Asia Pacific is expected to grow from US$ 540.25 million in 2021 to US$ 871.63 million by 2028; it is estimated to grow at a CAGR of 7.1% from 2021 to 2028.
The biotechnology sector in Asia Pacific is proliferating with heavy investments and strategic developments between private and public organizations. For instance, in December 2019, Astellas Pharma Inc. (Japan) signed an agreement to acquire Audentes Therapeutics Inc., a gene therapy company, for US$ 3 billion. Similarly, in November 2019, Fujifilm invested ~US$ 120 million (JPY 13 billion) in gene therapy as a part of the contract development and manufacturing segment of the organization. In addition, the Japan Pharmaceutical Medical Device Agency approved two gene therapy products. The products were approved simultaneously under Sakigake designation, equivalent to the FDA breakthrough therapy designation, and the EMA Priority Medicine (PRIME) designation. The agency is expected to approve at least one therapy per year. Strategic developments in the cell therapy domain by the domestic players in Asian countries are likely to increase the demand for cell therapy in the coming years. Since the approval of Gendicine for the treatment of head-and-neck squamous cell carcinoma by substituting affected copies of the p53 tumor suppressor gene with normal gene copies, China has expanded cell therapy applications and increased cell therapy production. For instance, in 2018, Taiwan held the ninth position for a regulatory agency to approve cell therapy's clinical application. In January 2020, the country introduced six autologous cell therapy treatments, including two for cancer, two for skin cell transplantation, and two for bone and cartilage regeneration. In Taiwan, four hospitals have licenses to provide cell therapies, and 26 more hospitals have already applied for a license to provide cell therapies. Therefore, rising awareness and use of cell therapy is expected to propel the adoption of biobanking in Asia Pacific. Furthermore, regenerative medicine research in cell therapy, gene therapy, and tissue engineering is rapidly growing in Asia Pacific countries. Also, rising geriatric population; increasing developments in healthcare services; surging requirement for transplants; and emerging personalized medicines in Japan, China, India, and South Korea would create demand for biobanking in the future. Thus, increasing adoption of cell therapy in developing regions is expected to fuel the demand for biobanking, which is likely to offer various growth opportunities for the biobanks market players during the forecast period.Countries in Asia Pacific are facing challenges due to increasing incidences of COVID-19. Shrinking economy of many countries is also going to affect many sectors including pharmaceutical. As per the Asian Development Bank (ADB), a group of 45 countries in the Asia Pacific region, is expected to post growth of just 0.1 per cent in 2020. The pandemic's expansion, combined with concerns about the economy's recovery, has harmed the region's pharmaceutical business. This economic impact is projected to have a detrimental influence on research and development investments. Some research institutes in the region are actively participating in research to determine the feasibility of coronavirus management. The coronavirus disease 2019 (COVID-19) pandemic has hampered non-communicable disease detection and treatment. COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the Asia pacific, especially affecting the worlds economically challenged.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific biobanks market. The Asia Pacific biobanks market is expected to grow at a good CAGR during the forecast period.
Asia Pacific Biobanks market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Biobanks Market Segmentation
Asia Pacific Biobanks Market – By Product and Service
- Equipment
- Storage Equipment
- Sample Analysis Equipment
- Sample Processing Equipment
- Sample Transport Equipment
- Consumables
- Storage Consumables
- Analysis Consumables
- Processing Consumables
- Collection Consumables
- Service
- Storage Services
- Processing Services
- Transport Services
- Supply Services
- Software
Asia Pacific Biobanks Market – By Sample
- Blood Products
- Human Tissues
- Cell Lines
- Others
Asia Pacific Biobanks Market – By Application
- Regenerative Medicine
- Life Science Research
- Clinical Research
Asia Pacific Biobanks Market – By Country
- China
- Japan
- India
- South Korea
- Australia
- Rest of APAC
Asia Pacific Biobanks Market – Companies Mentioned
- THERMO FISHER SCIENTIFIC INC.
- Tecan Trading AG
- QIAGEN
- Hamilton Company
- Avantor, Inc.
- MICRONICS JAPAN CO., LTD.
- BD
- Taylor-Wharton
- Brooks Automation, Inc.
- Promega Corporation
- SciSafe Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Biobanks Market – By Product and Service
1.3.2 Asia Pacific Biobanks Market – By Sample
1.3.3 Asia Pacific Biobanks Market – By Application
1.3.4 Asia Pacific Biobanks Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Biobanks Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. Asia Pacific Biobanks Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Funding and Genomic Research Activities for Studying Diseases
5.1.2 Scaling Adoption of Regenerative Medicines
5.2 Market Restraints
5.2.1 Extensive Cost of Automation
5.3 Market Opportunities
5.3.1 Raising Adoption of Cell Therapy in Developing Regions
5.4 Future Trends
5.4.1 Virtual Biobanks
5.5 Impact Analysis
6. Asia Pacific Biobanks Market Analysis
6.1 Asia Pacific Biobanks Market Revenue Forecast and Analysis
6.2 Asia Pacific: Biobanks Market - Revenue and Forecast to 2028 (USD Million)
7. Asia Pacific Biobanks Market – by Product and Service
7.1 Overview
7.2 Asia Pacific Biobanks Market, By Product and Service, 2021 & 2028 (%)
7.3 Equipment
7.3.1 Overview
7.3.2 Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
7.3.2.1 Storage Equipment
7.3.2.1.1 Overview
7.3.2.1.2 Storage Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Sample Analysis Equipment
7.3.2.2.1 Overview
7.3.2.2.2 Sample Analysis Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Sample Processing Equipment
7.3.2.3.1 Overview
7.3.2.3.2 Sample Processing Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.4 Sample Transport Equipment
7.3.2.4.1 Overview
7.3.2.4.2 Sample Transport Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.4 Consumables
7.4.1 Overview
7.4.2 Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
7.4.2.1 Storage Consumables
7.4.2.1.1 Overview
7.4.2.1.2 Storage Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.4.2.2 Analysis Consumables
7.4.2.2.1 Overview
7.4.2.2.2 Analysis Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.4.2.3 Processing Consumables
7.4.2.3.1 Overview
7.4.2.3.2 Processing Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.4.2.4 Collection Consumables
7.4.2.4.1 Overview
7.4.2.4.2 Collection Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.5 Services
7.5.1 Overview
7.5.2 Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
7.5.2.1 Storage Services
7.5.2.1.1 Overview
7.5.2.1.2 Storage Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.5.2.2 Processing Services
7.5.2.2.1 Overview
7.5.2.2.2 Processing Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.5.2.3 Transport Services
7.5.2.3.1 Overview
7.5.2.3.2 Transport Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.5.2.4 Supply Services
7.5.2.4.1 Overview
7.5.2.4.2 Supply Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.6 Software
7.6.1 Overview
7.6.2 Software: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
8. Asia Pacific Biobanks Market – By Sample
8.1 Overview
8.2 Asia Pacific Biobanks Market Share by Application - 2021 & 2028 (%)
8.3 Blood Products
8.3.1 Overview
8.3.2 Blood Products: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
8.4 Human Tissues
8.4.1 Overview
8.4.2 Human Tissues: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
8.5 Cell Lines
8.5.1 Overview
8.5.2 Cell Lines: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Biobanks Market – By Application
9.1 Overview
9.2 Asia Pacific Biobanks Market Share by Application - 2021 & 2028 (%)
9.3 Regenerative Medicine
9.3.1 Overview
9.3.2 Regenerative Medicine: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
9.4 Life Science Research
9.4.1 Overview
9.4.2 Life Science Research: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
9.5 Clinical Research
9.5.1 Overview
9.5.2 Clinical Research: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Biobanks Market – Country Analysis
10.1 Overview
10.1.1 Asia Pacific: Biobanks Market, by Country, 2021 & 2028 (%)
10.1.1.1 China: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3 China: Biobanks Market, by Product and Service, 2019–2028 (USD Million)
10.1.1.1.3.1 China: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.1.1.1.3.2 China: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.1.1.1.3.3 China: Biobanks Market, by Services, 2019–2028 (USD Million)
10.1.1.1.4 China: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.1.1.5 China: Biobanks Market, by Application, 2019–2028 (USD Million)
10.1.1.2 Japan: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3 Japan: Biobanks Market, by Product and Service, 2019–2028 (USD Million)
10.1.1.2.3.1 Japan: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.1.1.2.3.2 Japan: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.1.1.2.3.3 Japan: Biobanks Market, by Services, 2019–2028 (USD Million)
10.1.1.2.4 Japan: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.1.2.5 Japan: Biobanks Market, by Application, 2019–2028 (USD Million)
10.1.1.3 India: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3 India: Biobanks Market, by Product and Service, 2019–2028 (USD Million)
10.1.1.3.3.1 India: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.1.1.3.3.2 India: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.1.1.3.3.3 India: Biobanks Market, by Services, 2019–2028 (USD Million)
10.1.1.3.4 India: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.1.3.5 India: Biobanks Market, by Application, 2019–2028 (USD Million)
10.1.1.4 South Korea: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3 South Korea: Biobanks Market, by Product and Service, 2019–2028 (USD Million)
10.1.1.4.3.1 South Korea: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.1.1.4.3.2 South Korea: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.1.1.4.3.3 South Korea: Biobanks Market, by Services, 2019–2028 (USD Million)
10.1.1.4.4 South Korea: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.1.4.5 South Korea: Biobanks Market, by Application, 2019–2028 (USD Million)
10.1.1.5 Australia: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.3 Australia: Biobanks Market, by Product and Service, 2019–2028 (USD Million)
10.1.1.5.3.1 Australia: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.1.1.5.3.2 Australia: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.1.1.5.3.3 Australia: Biobanks Market, by Services, 2019–2028 (USD Million)
10.1.1.5.4 Australia: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.1.5.5 Australia: Biobanks Market, by Application, 2019–2028 (USD Million)
10.1.1.6 Rest of Asia Pacific: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.3 Rest of Asia Pacific: Biobanks Market, by Product and Service, 2019–2028 (USD Million)
10.1.1.6.3.1 Rest of Asia Pacific: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.1.1.6.3.2 Rest of Asia Pacific: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.1.1.6.3.3 Rest of Asia Pacific: Biobanks Market, by Services, 2019–2028 (USD Million)
10.1.1.6.4 Rest of Asia Pacific: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.1.6.5 Rest of Asia Pacific: Biobanks Market, by Application, 2019–2028 (USD Million)
11. Impact Of COVID-19 Pandemic on Asia Pacific Biobanks Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Asia Pacific Biobanks Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Tecan Trading AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Hamilton Company
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Avantor, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 MICRONICS JAPAN CO., LTD.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BD
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Taylor-Wharton
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Brooks Automation, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Promega Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 SciSafe Inc.
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. China: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 2. China Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 3. China Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 4. China Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 5. China: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 6. China: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 8. Japan Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 9. Japan Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 10. Japan Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 11. Japan: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 12. Japan: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. India: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 14. India Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 15. India Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 16. India Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 17. India: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 18. India: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 21. South Korea Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 22. South Korea Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 23. South Korea: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 24. South Korea: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 25. Australia: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 26. Australia Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 27. Australia Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 28. Australia Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 29. Australia: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 30. Australia: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of Asia Pacific: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Asia Pacific Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Asia Pacific Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of Asia Pacific Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of Asia Pacific: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Asia Pacific: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 37. Organic Developments Done By Companies
Table 38. Inorganic Developments Done by Companies
Table 39. Glossary of Terms
LIST OF FIGURES
Figure 1. Asia Pacific Biobanks Market Segmentation
Figure 2. Asia Pacific Biobanks Market, By Country
Figure 3. Asia Pacific Biobanks Market Overview
Figure 4. Equipment Segment Held Largest Share of Product and Service Segment in Asia Pacific Biobanks Market
Figure 5. China is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Asia Pacific Biobanks Market, Industry Landscape
Figure 7. Asia Pacific: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Asia Pacific Biobanks Market Revenue and Forecast to 2028 (USD Million)
Figure 10. Asia Pacific Biobanks Market, by Product and Service, 2021 & 2028 (%)
Figure 11. Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Storage Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Sample Analysis Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Sample Processing Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Sample Transport Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Storage Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Analysis Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Processing Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Collection Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Storage Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Processing Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Transport Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Supply Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Software: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Asia Pacific Biobanks Market Share by Application - 2021 & 2028 (%)
Figure 28. Blood Products: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Human Tissues: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Cell Lines: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Others: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Asia Pacific Biobanks Market Share by Application - 2021 & 2028 (%)
Figure 33. Regenerative Medicine: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. Life Science Research: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Clinical Research: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Asia Pacific: Biobanks Market, by Key Country – Revenue (2021) (USD Million)
Figure 37. Asia Pacific: Biobanks Market, by Country, 2021 & 2028 (%)
Figure 38. China: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Japan: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. India: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. South Korea: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Australia: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. Rest of Asia Pacific: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 44. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- THERMO FISHER SCIENTIFIC INC.
- Tecan Trading AG
- QIAGEN
- Hamilton Company
- Avantor, Inc.
- MICRONICS JAPAN CO., LTD.
- BD
- Taylor-Wharton
- Brooks Automation, Inc.
- Promega Corporation
- SciSafe Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific biobanks market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific biobanks market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the biobanks market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
-
$2000
-
$3000
-
$4000
-
$5000
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount